Latest filing published 24 Jun 2026 for Immuneering Corp.
Filing timeline
BuySaleInsider track record
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Benjamin J. Zeskind: trading record in brief
All filings by Benjamin J. Zeskind on record concern Immuneering Corp, in the capacity of chief executive. We count 12 filings; the first trade dates from 3 August 2021 and the latest from 23 June 2026.
Purchases make up the whole of the open-market record (8 purchases, €222k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 3 option exercises. 2026 to date brings 1 purchase and no sales.
In size, the median ticket on the buying side is €24k. 6 out of 8 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
Most recently, on 24 June 2026, the filings show an open-market purchase worth €9,621 in Immuneering Corp. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Benjamin J. Zeskind
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,400 sharesClass A Common StockSEC:0001790340-26-000078:0Canonical exit: 21 Sept 2026 (T+90)
- 2,985 shares@ US$3.37924.7% of flowClass A Common StockSEC:0001790340-25-000094:0Canonical exit: 29 Sept 2025 (T+90)
- 21,000 shares@ US$2.387825.0% of flowClass A Common StockSEC:0001790340-25-000081:0Canonical exit: 16 Sept 2025 (T+90)
- 20,000 shares@ US$2.766329.7% of flowClass A Common StockSEC:0001790340-24-000026:0Canonical exit: 17 Jun 2024 (T+90)
- 2,500 shares@ US$3.014.1% of flowClass A Common StockSEC:0001415889-22-012975:0
- 2,000 shares@ US$3.013.0% of flowClass A Common StockSEC:0001415889-22-004065:0
- 3,000 shares@ US$8.0211.9% of flowClass A Common StockSEC:0001415889-22-003324:0Canonical exit: 21 Jun 2022 (T+90)
- 2,000 shares@ US$3.012.9% of flowClass A Common StockSEC:0001415889-22-002061:0
- 2,083 shares@ US$22.86722.0% of flowClass A Common StockSEC:0001415889-21-004382:0Canonical exit: 12 Dec 2021 (T+90)
- 49,099 sharesClass A Common StockSEC:0001104659-21-099741:0
10 of 10 declarations
